Akanda Corp. (AKAN) — 6-K Filings

6-K Filings (50)

• 6-K Filing — Apr 9, 2026
• 6-K Filing — Mar 31, 2026
• 6-K Filing — Dec 18, 2025
• Akanda Corp. Shareholder Meeting Held Nov 28 — Dec 2, 2025 Risk: low
  Akanda Corp. held a Special Meeting of Shareholders on November 28, 2025, which was adjourned from October 30, 2025. Out of 728,238 common shares eligible to vo
• 6-K Filing — Nov 13, 2025
• Akanda Corp. Adjourns Shareholder Meeting to Nov 28 — Nov 10, 2025 Risk: low
  Akanda Corp. has furnished documents related to its Special Meeting of Shareholders, originally scheduled for October 30, 2025, and adjourned to November 28, 20
• Akanda Corp. Adjourns Shareholder Meeting to November 28 — Oct 31, 2025 Risk: low
  Akanda Corp. held a special meeting of its shareholders on October 30, 2025, which was adjourned to November 28, 2025. The meeting will reconvene at the offices
• Akanda Corp. Files October 2025 Report — Oct 20, 2025 Risk: low
  Akanda Corp. filed a Form 6-K on October 20, 2025, reporting its activities for the month of October 2025. The filing includes a press release dated October 20,
• Akanda Corp. Files 6-K, Reports Press Release — Oct 17, 2025 Risk: low
  Akanda Corp. filed a Form 6-K on October 17, 2025, reporting a press release dated October 16, 2025. The filing indicates that Katie Field, Interim Chief Execut
• Akanda Corp. Warns of Postal Strike Impact on Shareholder Meeting — Oct 10, 2025 Risk: medium
  Akanda Corp. issued a press release on October 10, 2025, regarding the impact of the ongoing Canadian postal strike on the delivery of shareholder proxy materia
• Akanda Corp. Schedules Shareholder Meeting for Oct 30 — Oct 9, 2025 Risk: low
  Akanda Corp. is holding a Special Meeting of Shareholders on October 30, 2025. The company is furnishing the Notice of Special Meeting, Management Information C
• Akanda Corp. Files September 2025 6-K Report — Oct 1, 2025 Risk: low
  Akanda Corp. filed a Form 6-K on October 1, 2025, for the month of September 2025. The report includes a Management's Discussion and Analysis of Financial Condi
• Akanda Corp. Extends Option Agreement to 2027 — Sep 26, 2025 Risk: low
  On September 24, 2025, Akanda Corp. entered into Amendment No. 1 to an Amended and Restated Option to Purchase with 1107385 B.C. LTD. This amendment extends the
• Akanda Corp. Raises $12M via Convertible Notes — Sep 16, 2025 Risk: medium
  On September 12, 2025, Akanda Corp. entered into a Securities Purchase Agreement with certain institutional investors to issue and sell convertible promissory n
• Akanda Corp. Raises $12M Via Convertible Note Offering — Sep 15, 2025 Risk: medium
  Akanda Corp. announced a $12.0 million convertible note offering on September 12, 2025. The company, operating in the medicinal chemicals and botanical products
• Akanda Corp. Holds Shareholder Meeting Post-Reverse Split — Aug 29, 2025 Risk: low
  Akanda Corp. held a Special Meeting of Shareholders on August 29, 2025, where a quorum was present. The meeting involved the consideration of a proposal, with 2
• Akanda Corp. Files 6-K with Press Release and Amendments — Aug 22, 2025 Risk: low
  Akanda Corp. filed a Form 6-K on August 22, 2025, reporting information for the month of August 2025. The filing includes a press release dated August 22, 2025,
• Akanda Corp. Calls Special Shareholder Meeting for August 29 — Aug 8, 2025 Risk: low
  Akanda Corp. is holding a Special Meeting of Shareholders on August 29, 2025, to discuss important matters. The company has furnished the Notice of Special Meet
• Akanda Corp. Holds Annual Shareholder Meeting, Votes on Directors — May 1, 2025 Risk: low
  Akanda Corp. held its Annual General and Special Meeting of Shareholders on April 30, 2025. Shareholders voted on proposals, including fixing the number of dire
• Akanda Corp. Appoints Usama Chaudhry to Board of Directors — Apr 18, 2025 Risk: low
  On April 10, 2025, Akanda Corp. announced the appointment of Usama Chaudhry to its Board of Directors, increasing the board's size. Mr. Chaudhry has been deemed
• Akanda Corp. Schedules 2025 Shareholder Meeting — Apr 16, 2025 Risk: low
  Akanda Corp. is holding its 2025 Annual General and Special Meeting of Shareholders on April 30, 2025. The company is furnishing the Notice of Meeting, Manageme
• Akanda Corp. Raises $320K in Private Share Offering — Apr 1, 2025 Risk: medium
  Akanda Corp. announced on or about March 25, 2025, that it entered into Subscription Agreements to sell 228,572 restricted common shares at $1.40 per share, rai
• Akanda Corp. Signs Share Exchange Agreement — Mar 11, 2025 Risk: medium
  On March 5, 2025, Akanda Corp. entered into a Share Exchange Agreement with First Towers & Fibers Corp. (FTFC) and FTFC's common shareholders. This agreement ou
• Akanda Corp. Loans $350,000 to First Towers & Fiber Corp. — Nov 26, 2024 Risk: low
  On November 22, 2024, Akanda Corp. entered into a Bridge Loan Agreement dated November 21, 2024, to loan US$350,000 to First Towers & Fiber Corp. First Towers i
• Akanda Corp. Files 6-K with Press Release and Amendments — Nov 12, 2024 Risk: low
  Akanda Corp. filed a Form 6-K on November 12, 2024, reporting information for the month of November 2024. This filing includes Exhibit 99.1, a press release dat
• Akanda Corp. Files 6-K with Financials for H1 2024 — Oct 30, 2024 Risk: medium
  Akanda Corp. filed a Form 6-K on October 30, 2024, reporting its financial condition and results of operations for the six months ended June 30, 2024, and 2023.
• Akanda Corp. Closes Public Offering, Pays Underwriter $37.5K — Oct 4, 2024 Risk: low
  On October 4, 2024, Akanda Corp. announced the successful closing of its underwritten public offering. Univest Securities, LLC served as the underwriter for thi
• Akanda Corp. Prices Public Offering — Oct 2, 2024 Risk: medium
  On October 2, 2024, Akanda Corp. announced the pricing of its underwritten public offering. The company, incorporated in the UK and operating in the medicinal c
• Akanda Corp. Files 6-K Report — Sep 16, 2024 Risk: low
  Akanda Corp. filed a Form 6-K on September 16, 2024, reporting for the month of September 2024. The filing includes a press release dated September 16, 2024, as
• Akanda Corp. Fails Nasdaq Equity Rule — Jul 25, 2024 Risk: high
  Akanda Corp. received a notification from Nasdaq on May 14, 2024, stating it is not in compliance with the minimum shareholders' equity requirement of $2.5 mill
• Akanda Corp. Completes F-3 Shelf Registration for $50M — Jun 14, 2024 Risk: medium
  Akanda Corp. announced on June 14, 2024, the completion of its F-3 shelf registration statement. This allows the company to potentially offer and sell up to $50
• Akanda Corp. Regains Nasdaq Minimum Bid Price Compliance — Jun 12, 2024 Risk: medium
  Akanda Corp. announced on June 12, 2024, that it has regained compliance with the Nasdaq Stock Market's minimum bid price requirement. This means the company's
• Akanda Corp. Files 6-K with Press Release and Amendments — May 23, 2024 Risk: low
  Akanda Corp. filed a Form 6-K on May 23, 2024, to report information for the month of May 2024. The filing includes a press release dated May 21, 2024, and Arti
• Akanda Corp. Completes Direct Share Offering — May 20, 2024 Risk: medium
  On May 17, 2024, Akanda Corp. completed a registered direct offering, selling 2,491,381 common shares to an accredited investor. The company is incorporated in
• Akanda Corp. Prices Registered Direct Offering — May 17, 2024 Risk: medium
  On May 17, 2024, Akanda Corp. announced the pricing of its registered direct offering. The filing does not specify the dollar amount or details of the offering,
• Akanda Corp. Faces Nasdaq Delisting Warning — May 16, 2024 Risk: high
  On May 16, 2024, Akanda Corp. announced it received a notice of non-compliance from Nasdaq. The company was not in compliance with Nasdaq Listing Rule 5550(a)(2
• Akanda Corp settles with former CEO Tejinder Virk — May 14, 2024 Risk: low
  On May 13, 2024, Akanda Corp. announced a settlement agreement with its former CEO, Tejinder Virk. The details of this settlement are provided in a press releas
• Akanda Corp. Eyes Global Expansion Post US Drug Policy Shift — May 10, 2024 Risk: medium
  On May 10, 2024, Akanda Corp. announced its intention to be an early mover in the international market, contingent upon a significant change in US drug policy.
• Akanda Corp. Appoints New Director to Board — Apr 26, 2024 Risk: low
  On April 25, 2024, Akanda Corp. announced the appointment of a new director, Cooper, to its Board of Directors. This appointment is detailed in a press release
• Akanda Corp. Halts Equity Financing — Apr 15, 2024 Risk: medium
  Akanda Corp. announced on April 15, 2024, that it will not pursue any equity financing until further notice. This decision was communicated via a press release
• Akanda Corp. Eyes Blockchain & AI Amid German Cannabis Legalization — Apr 12, 2024 Risk: medium
  On April 12, 2024, Akanda Corp. announced its intention to enter the blockchain and AI technology sector. This move is in anticipation of Germany's legalization
• Akanda Corp. Sells Subsidiary, Pays $446K Finder's Fee — Apr 11, 2024 Risk: medium
  On April 11, 2024, Akanda Corp. announced the closing of the sale of its indirect wholly-owned Portuguese subsidiary, RPK Biopharma Unipessoal, Lda. In connecti
• Akanda Corp. Hires IR Agency for $750K Marketing Deal — Mar 28, 2024 Risk: medium
  On March 22, 2024, Akanda Corp. entered into a one-year Consulting Agreement with IR Agency LLC. IR Agency will provide marketing and advertising services, incl
• Akanda Corp. Closes Public Offering, Pays $200K to Underwriter — Mar 27, 2024 Risk: medium
  On March 27, 2024, Akanda Corp. announced the closing of its underwritten public offering. Univest Securities, LLC acted as the underwriter and received $200,00
• Akanda Corp. Prices Public Offering — Mar 25, 2024 Risk: medium
  On March 25, 2024, Akanda Corp. announced the pricing of its underwritten public offering. The details of the offering, including the number of shares and the p
• Akanda Corp. Holds Annual Shareholder Meeting, Elects Directors — Mar 22, 2024 Risk: low
  Akanda Corp. held its Annual General and Special Meeting of Shareholders on March 22, 2024. A total of 2,431,954 common shares were voted out of 5,628,295 eligi
• Akanda Corp. Schedules 2024 Shareholder Meeting — Mar 11, 2024 Risk: low
  Akanda Corp. is holding its 2024 Annual General and Special Meeting of Shareholders on March 22, 2024. The company has furnished the Notice of Meeting, Manageme
• Akanda Corp. Completes Registered Direct Offering — Mar 6, 2024 Risk: medium
  On March 4, 2024, Akanda Corp. completed a registered direct offering, selling 367,870 common shares to accredited investors. The company, organized under Ontar
• Akanda Corp. Completes Registered Direct Offering — Mar 5, 2024 Risk: medium
  On March 1, 2024, Akanda Corp. completed a registered direct offering, selling 367,870 common shares to accredited investors. The company, organized under the l
• Akanda Corp. Completes Registered Direct Offering — Mar 1, 2024 Risk: medium
  On March 1, 2024, Akanda Corp. completed a registered direct offering, selling 367,870 common shares to accredited investors. The company is incorporated in Ont

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX